+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 511 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2785211
The global market for Hemoglobin A1C (HbA1C) Testing is estimated at US$1.3 Billion in 2023 and is projected to reach US$2.3 Billion by 2030, growing at a CAGR of 8.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the Hemoglobin A1C (HbA1c) testing market is driven by several factors. Firstly, the rising prevalence of diabetes worldwide is increasing the demand for regular HbA1c testing to manage and diagnose the condition effectively. Secondly, advancements in diagnostic technology are making HbA1c tests more accurate and accessible, enhancing their adoption in both clinical and home settings. Thirdly, the growing emphasis on preventive healthcare and early diagnosis of diabetes is driving the market for HbA1c testing as a key component of diabetes management programs. Lastly, increasing awareness and education about diabetes and its complications are encouraging more frequent and consistent testing among at-risk populations. These factors collectively ensure the continued growth and importance of the HbA1c testing market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Ion-Exchange High Performance Liquid Chromatography (HPLC) Technology segment, which is expected to reach US$915.7 Million by 2030 with a CAGR of a 8.8%. The Immunoassays Technology segment is also set to grow at 9.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $386.6 Million in 2023, and China, forecasted to grow at an impressive 10.6% CAGR to reach $274.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Hemoglobin A1C (HbA1C) Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Hemoglobin A1C (HbA1C) Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Hemoglobin A1C (HbA1C) Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 110 Featured):

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • Apex Biotechnology Corporation
  • Axis-Shield Diagnostics Ltd.
  • Agappe Diagnostics Ltd.
  • Biorex Diagnostics
  • Boditech Med, Inc.
  • Biosurfit SA
  • Accruex Biomedical Pvt., Ltd.
  • Ailex Technology Group Co., Ltd.
  • American Screening Corporation, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Competition
  • Hemoglobin A1C (HbA1C) Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Hemoglobin A1C (HbA1C) Testing Competitor Market Share Scenario Worldwide (in %): 2022E
  • HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
  • Role of HbA1c Testing in Diabetes Diagnosis and Management
  • Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association
  • Global Market Analysis and Prospects
  • World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth
  • While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth
  • Chromatography-based Hb Testing Devices Lead Market
  • Ion-Exchange HPLC Test for Hemoglobin A1c Makes Notable Headway as Reliable Diabetes Screening Tool
  • HPLC Testing for HbA1c Retains Value as Gold Standard
  • Ion-exchange HPLC Testing: Primary Merits for Different Stakeholders
  • HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes
  • Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing
  • Recent Market Activity
  • WORLD BRANDS
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
  • World Diabetes Prevalence (2000-2045P)
  • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • Diabetes Emerges as One of the Leading Causes of Mortality
  • Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
  • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
  • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
  • Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
  • Laboratory-based HbA1c Testing Products/Analyzers of Select Players
  • Major Testing Methods in POC HbA1c Tests
  • High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Increasing Obesity Levels Underpins Market Growth
  • Average Per Capita Annual Health Expenditure (In US$) due to Obesity
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
  • Variants & Derivatives Affecting Accuracy of HbA1c Testing
  • Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
  • Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
  • Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
  • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
  • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
  • Technology Developments Transform Diagnostics in Diabetes Care
  • Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
  • Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
  • HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
  • Home HbA1C Testing Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Hemoglobin A1C (HbA1C) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Market Facts & Figures
  • US Hemoglobin A1C (HbA1C) Testing Market Share (in %) by Company: 2022 & 2030
  • Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share Analysis (in %) of Leading Players in the US for 2022 & 2030
  • Immunoassays (Technology) Competitor Revenue Share (in %) in the US: 2022 & 2030
  • Boronate Affinity Chromatography (Technology) Market Share Breakdown (in %) of Major Players in the US: 2022 & 2030
  • Direct Enzymatic Assays (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2022 & 2030
  • Market Analytics
CANADAJAPANCHINA
EUROPE
  • Market Facts & Figures
  • European Hemoglobin A1C (HbA1C) Testing Market: Competitor Market Share Scenario (in %) for 2022 & 2030
  • Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share (in %) by Company in Europe: 2022 & 2030
  • Immunoassays (Technology) Market Share (in %) of Major Players in Europe: 2022 & 2030
  • Boronate Affinity Chromatography (Technology) Competitor Market Share Analysis (in %) in Europe: 2022 & 2030
  • Direct Enzymatic Assays (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2022 & 2030
  • Market Analytics
FRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAREST OF EUROPEASIA-PACIFICAUSTRALIAINDIASOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICAARGENTINABRAZILMEXICOREST OF LATIN AMERICAMIDDLE EASTIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTAFRICAIV. COMPETITION

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • Apex Biotechnology Corporation
  • Axis-Shield Diagnostics Ltd.
  • Agappe Diagnostics Ltd.
  • Biorex Diagnostics
  • Boditech Med, Inc.
  • Biosurfit SA
  • Accruex Biomedical Pvt., Ltd.
  • Ailex Technology Group Co., Ltd.
  • American Screening Corporation, Inc.

Table Information